Tiansheng Pharmaceutical Group Co Ltd Net Asset Quality Index
Tiansheng Pharmaceutical Group Co Ltd net asset quality index. Tiansheng Pharmaceutical Group Co Ltd (002872) has a Net Asset Quality Index of 74.4% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥2.65 Billion minus total liabilities of CN¥679.17 Million yields net assets of CN¥1.97 Billion. A higher index indicates a stronger, lower-leverage balance sheet. See shareholders equity of Tiansheng Pharmaceutical Group Co Ltd for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Tiansheng Pharmaceutical Group Co Ltd (2012–2024)
Net asset quality index of Tiansheng Pharmaceutical Group Co Ltd from 2012 to 2024. This chart shows how Tiansheng Pharmaceutical Group Co Ltd's Net Asset Quality Index has evolved across 13 annual periods from 2012 to 2024. As of September 2025, the index stands at 74.4%, representing net assets of CN¥1.97 Billion against total assets of CN¥2.65 Billion CNY. Check 002872 strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.
Tiansheng Pharmaceutical Group Co Ltd Net Asset Quality Index by Year (2012–2024)
Tiansheng Pharmaceutical Group Co Ltd net asset quality index by year from 2012 to 2024. The table below presents the year-by-year Net Asset Quality Index for Tiansheng Pharmaceutical Group Co Ltd from 2012 to 2024, covering 13 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see how much is Tiansheng Pharmaceutical Group Co Ltd worth.
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 73.6% | CN¥2.01 Billion | CN¥2.74 Billion | CN¥721.80 Million | ▼ -0.9 pp |
| 2023 | 74.6% | CN¥2.10 Billion | CN¥2.81 Billion | CN¥715.25 Million | ▲ +0.9 pp |
| 2022 | 73.7% | CN¥2.19 Billion | CN¥2.97 Billion | CN¥782.23 Million | ▲ +0.6 pp |
| 2021 | 73.1% | CN¥2.28 Billion | CN¥3.12 Billion | CN¥840.79 Million | ▲ +7.5 pp |
| 2020 | 65.5% | CN¥2.39 Billion | CN¥3.65 Billion | CN¥1.26 Billion | ▼ -1.7 pp |
| 2019 | 67.3% | CN¥2.95 Billion | CN¥4.39 Billion | CN¥1.44 Billion | ▼ -0.8 pp |
| 2018 | 68.1% | CN¥3.18 Billion | CN¥4.67 Billion | CN¥1.49 Billion | ▲ +3.6 pp |
| 2017 | 64.5% | CN¥3.19 Billion | CN¥4.95 Billion | CN¥1.76 Billion | ▲ +9.7 pp |
| 2016 | 54.8% | CN¥1.86 Billion | CN¥3.39 Billion | CN¥1.53 Billion | ▼ -2.0 pp |
| 2015 | 56.8% | CN¥1.63 Billion | CN¥2.87 Billion | CN¥1.24 Billion | ▼ -0.5 pp |
| 2014 | 57.4% | CN¥1.43 Billion | CN¥2.50 Billion | CN¥1.06 Billion | ▲ +7.4 pp |
| 2013 | 49.9% | CN¥1.08 Billion | CN¥2.16 Billion | CN¥1.08 Billion | ▼ -4.6 pp |
| 2012 | 54.6% | CN¥951.66 Million | CN¥1.74 Billion | CN¥792.28 Million | — |